相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activity and complexes of mTOR in diffuse large B-cell lymphomas-a tissue microarray study
Anna Sebestyen et al.
MODERN PATHOLOGY (2012)
The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia
Philip Saunders et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
A spectrophotometric assay for routine measurement of mammalian target of rapamycin activity in cell lysates
Hinke E. Dekter et al.
ANALYTICAL BIOCHEMISTRY (2010)
Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development
Alisa B. Lee-Sherick et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Rapamycin sensitizes T-ALL cells to dexamethasone-induced apoptosis
Ling Gu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
Matthew R. Janes et al.
NATURE MEDICINE (2010)
Profile of temsirolimus in the treatment of advanced renal cell carcinoma
Michael Staehler et al.
ONCOTARGETS AND THERAPY (2010)
Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia
Roman Crazzolara et al.
BLOOD (2009)
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
Alejandro Gutierrez et al.
BLOOD (2009)
Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies
David T. Teachey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
A Phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL)
Michael A. Pulsipher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Temsirolimus in Mantle Cell Lymphoma and Other Non-Hodgkin Lymphoma Subtypes
Georg Hess et al.
SEMINARS IN ONCOLOGY (2009)
Novel targeted drug therapies I for the treatment of childhood acute leukemia
Patrick Brown et al.
EXPERT REVIEW OF HEMATOLOGY (2009)
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia
David T. Teachey et al.
BLOOD (2008)
Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
Bing-Hua Jiang et al.
DRUG RESISTANCE UPDATES (2008)
Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis
L. Gu et al.
LEUKEMIA (2008)
Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2008)
Phase I study of everolimus in pediatric patients with refractory solid tumors
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Rapamycin regulates the phosphorylation of rictor
Argun Akcakanat et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
Jennifer O'Neil et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance
Guo Wei et al.
CANCER CELL (2006)
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies
Karen W. L. Yee et al.
CLINICAL CANCER RESEARCH (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL
DT Teachey et al.
BLOOD (2006)
Drug therapy - Treatment of acute lymphoblastic leukemia
CH Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Childhood leukaemia incidence in hungary, 1973-2002. Interpolation model for analysing the possible effects of the Chernobyl accident
S Török et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2005)
Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells
R Avellino et al.
BLOOD (2005)
MTOR-targeted therapy of cancer with rapamycin derivatives
S Vignot et al.
ANNALS OF ONCOLOGY (2005)
Mammalian target of rapamycin (mTOR) inhibition in chronic lymphocytic B-cell leukemia: A new therapeutic option
I Ringshausen et al.
LEUKEMIA & LYMPHOMA (2005)
Dysregulation of the TSC-mTOR pathway in human disease
K Inoki et al.
NATURE GENETICS (2005)
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
LS Steelman et al.
LEUKEMIA (2004)
Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by Il-7-mediated signalling
VI Brown et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia
CH Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
TOR, a central controller of cell growth
T Schmelzle et al.
CELL (2000)
分享论文
